New application of stachyose, feed additive and application of stachyose

The combination of soy isoflavones and stachyose in a feed additive addresses the bioavailability issue of soy isoflavones in Chinese mitten crabs, improving lipid metabolism and reducing oxidative stress, thereby enhancing growth and health in these crustaceans.

CN119054808APending Publication Date: 2024-12-03EAST CHINA NORMAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411295302.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-17
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The bioavailability of soy isoflavones is reduced in Chinese mitten crabs due to first-pass metabolism and efflux transport in the intestine, leading to impaired lipid metabolism and oxidative stress from high-fat diets, with existing feed additives failing to effectively address these issues.

Method used

A feed additive comprising soy isoflavones and stachyose is used to inhibit intestinal degradation and enhance the absorption and utilization of soy isoflavones, regulating lipid metabolism by reducing the expression of phase II metabolic enzymes and efflux transporters, and activating the AMPK pathway to optimize lipid metabolism.

Benefits of technology

The synergistic effect of soy isoflavones and stachyose improves lipid metabolism, reduces lipid accumulation, enhances antioxidant capacity, and promotes healthy growth in Chinese mitten crabs, providing a scientific basis for optimizing feed formulations and sustainable aquaculture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119054808A_ABST
    Figure CN119054808A_ABST
Patent Text Reader

Abstract

The invention discloses novel application of stachyose, a feed additive and application of the feed additive, and relates to the technical field of aquatic feed. Wherein the bioavailability of the soy isoflavone can be improved by the stachyose. Meanwhile, the invention discloses a feed additive for improving lipid metabolism of eriocheir sinensis, the feed additive comprises soy isoflavone and stachyose, and per kilogram of feed comprises the following feed additives by weight: 30-50mg of soy isoflavone and 10-15g of stachyose. The feed additive can be used for improving lipid metabolism of the eriocheir sinensis. The invention shows that the soybean isoflavone and the stachyose have a synergistic effect in improving the lipid metabolism of the river crabs in the high-fat feed, a new idea is provided for the application of the soybean isoflavone in the crustacean animal feed, and a technical innovation is provided for developing a feed additive and a functional compound feed; the invention provides a scientific basis for optimizing a feed formula and healthy breeding of the river crabs, and has important significance for promoting green and sustainable development of the river crab breeding industry.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of aquatic feed, and in particular to new uses of stachyose, feed additives and applications thereof. Background Art

[0002] The rapid development of modern aquaculture is mainly due to the optimization of feed formulation and the advancement of aquaculture technology. By improving feed formulation, feed efficiency can be significantly improved and costs can be reduced. For example, it has become a common practice to supplement feed additives to improve feed quality, promote the growth of aquatic animals and prevent diseases. Therefore, it is crucial to find excellent additives to optimize feed formulations for aquaculture. At the same time, lipids are also considered to be a lower-cost ingredient compared to proteins. In recent years, high-fat feeds have been used to save protein in aquaculture. However, excessive lipid content in feed can lead to abnormal lipid deposition and oxidative stress, which can lead to metabolic disorders and impair the growth, health and quality of aquatic animals. Therefore, it is necessary to develop an appropriate strategy to improve the utilization of lipids in feed to promote growth. Plant natural compounds are biocompatible and provide bioactive secondary metabolites to play a pleiotropic role; they have good biodegradability and can be naturally degraded in or outside aquatic animals without causing harm to the health of aquatic animals. They are a sustainable, green and healthy method.

[0003] Soy isoflavones are a type of non-steroidal polyphenolic secondary metabolite produced during the growth of soybeans. It has 12 isomers, which can be divided into two categories: aglycones (about 3% of the total) and glycosides (about 97% of the total). Mammalian studies have shown that soy isoflavones have a wide range of biological functions, such as anti-oxidation, anti-inflammatory, inhibition of cancer cell growth, and prevention of osteoporosis. The addition of soy isoflavones to feed plays a vital role in regulating the growth and immune response of aquatic animals. For example, the addition of 40 mg / kg of soy isoflavones to feed can significantly improve the growth, nonspecific immunity and antioxidant capacity of oval pomfret. In addition, increasing evidence shows that isoflavones can also regulate lipid metabolism. Researchers have conducted a large number of experiments at the cellular level, mouse models, livestock, and humans, and found that isoflavones can reduce lipid synthesis and increase fatty acid oxidation and decomposition.

[0004] Chinese mitten crab (also known as river crab, hairy crab) is widely cultivated in my country as an economic crustacean due to its delicious taste and nutritional value. Although soy isoflavones have significant functions in mammals and some fish, there has been no systematic study on their role in the economic crustacean Chinese mitten crab.

[0005] Therefore, exploring the effects of soy isoflavones on the economic crustacean Chinese mitten crab and how to improve the bioavailability of soy isoflavones are problems that need to be solved in the present invention. Summary of the invention

[0006] The new use of stachyose, feed additive and application thereof provided by the present invention are intended to solve the problems existing in the above-mentioned background technology.

[0007] In order to achieve the above technical objectives, the present invention mainly adopts the following technical solutions:

[0008] In a first aspect, the present invention discloses the use of stachyose in improving the bioavailability of soybean isoflavones.

[0009] Stachyose is an excellent dietary fiber and prebiotic, and one of the most well-known and commonly used oligosaccharides, which is widely considered in the nutritional recommendations for metabolic syndrome. Isoflavones are prone to first-pass metabolism and efflux transport in the phase II metabolism of the intestine, which affects the absorption and utilization of isoflavones and the amount of isoflavones transported to the blood circulation, thereby reducing their bioavailability.

[0010] The mechanism by which stachyose in the present invention promotes the absorption and utilization of soybean isoflavones is that it can strongly inhibit the intestinal degradation of soybean isoflavones and the expression of phase II metabolic enzymes and efflux transporters in the intestine.

[0011] In a second aspect, the present invention discloses a feed additive for improving lipid metabolism of Chinese mitten crab, wherein the feed additive comprises soybean isoflavones and stachyose.

[0012] In a preferred embodiment of the present invention, per kilogram of feed, the feed additives include the following weights: 30-50 mg of soy isoflavones and 10-15 g of stachyose. Preferably, per kilogram of feed, the feed additives include the following weights: 40 mg of soy isoflavones and 12.42 g of stachyose.

[0013] In a third aspect, the present invention discloses a use of the feed additive as described in the second aspect in preparing a feed capable of improving lipid metabolism of Chinese mitten crab.

[0014] In a preferred embodiment of the present invention, the feed additive significantly reduces the crude fat content in the whole crab and hepatopancreas of Chinese mitten crab.

[0015] In a preferred embodiment of the present invention, the feed additive significantly reduces the expression of intestinal phase II metabolic enzymes and efflux transporter genes in Chinese mitten crabs, significantly upregulates the expression of intestinal phase II metabolic enzyme genes in the hepatopancreas, and improves β-GC enzyme activity.

[0016] In a preferred embodiment of the present invention, the feed additive significantly reduces the content of TG, T-CHO and NEFA in the hepatopancreas of Chinese mitten crab.

[0017] In a preferred embodiment of the present invention, the feed additive significantly reduces the content of LDL-C in the hemolymph of Chinese mitten crab.

[0018] In a preferred embodiment of the present invention, the feed additive effectively enhances the antioxidant capacity of the hepatopancreas of Chinese mitten crab and inhibits the oxidative stress induced by a high-fat diet.

[0019] In a preferred embodiment of the present invention, the feed additive reduces the PI3K / AKT pathway and activates the AMPK pathway, thereby downregulating the fat synthesis genes srebp1, elovl6, fas, dagt, △9fad and the fatty acid uptake genes fabp3, fabp9, fabp10, and upregulating the fatty acid decomposition genes cpt1a, cpt1b, cpt2 and the fat transport gene mttp, so as to optimize the abnormal lipid metabolism caused by high-fat feed and reduce lipid accumulation in the hepatopancreas.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] The present invention shows that soybean isoflavones and stachyose have a synergistic effect in improving the lipid metabolism of river crabs in high-fat feeds, provides new ideas for the application of soybean isoflavones in crustacean feeds, provides technical innovation for the development of feed additives and functional compound feeds, and provides a scientific basis for optimizing feed formulations and healthy breeding of river crabs, which is of great significance for promoting the green and sustainable development of the river crab breeding industry. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is a comparison chart of the growth performance and liver-to-body ratio of the crabs in the control group and each experimental group;

[0023] Figure 2 This is a comparison chart of the body composition of river crabs in the control group and each experimental group;

[0024] Figure 3 It is a comparison chart of the gene expression or enzyme activity related to soybean isoflavone metabolism in the crabs in the control group and each experimental group;

[0025] Figure 4 This is a comparison chart of the hepatopancreas physiological and biochemical indicators of the crabs in the control group and each experimental group;

[0026] Figure 5 This is a comparison chart of hemolymph physiological and biochemical indicators of the crab in the control group and each experimental group;

[0027] Figure 6 This is a comparison chart of the antioxidant capacity of the hepatopancreas of crabs in the control group and each experimental group;

[0028] Figure 7This is a comparison chart of the lipid metabolism capacity of river crabs in the control group and each experimental group, where the data were transformed using logarithms, red represents up-regulated gene expression, and blue represents down-regulated gene expression. DETAILED DESCRIPTION

[0029] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0030] The present invention found that high-fat diet can reduce the bioavailability of soy isoflavones and affect its regulatory effect on lipid metabolism while causing lipid accumulation in river crabs, causing oxidative stress, and increasing the crude fat content of whole crabs. The combined supplementation of stachyose significantly improved the bioavailability of soy isoflavones, and enhanced the metabolic utilization of soy isoflavones in the hepatopancreas by reducing the expression of phase II metabolic enzymes and efflux transporters in the intestine, thereby effectively reducing the liver-to-body ratio and lipid accumulation of river crabs. Soy isoflavones may affect the expression of fat synthesis and decomposition genes, optimize lipid metabolism, and reduce lipid accumulation in the hepatopancreas by regulating the PI3K / AKT and AMPK signaling pathways. This study revealed the synergistic effect of soy isoflavones and stachyose in improving the lipid metabolism of river crabs in high-fat diets, providing a scientific basis for optimizing feed formulations and healthy breeding of river crabs.

[0031] The following is an explanation through specific embodiments.

[0032] Example 1

[0033] In this embodiment, casein and gelatin are used as the main protein sources, and fish oil, soybean oil, lecithin and cholesterol are used as the main fat sources. Experimental feeds with a crude protein content of about 44.0% and two fat levels (7.0% and 13.0%) are prepared. The specific formula and approximate composition are shown in Table 1. The production process of the feed is to grind all the feed raw materials first and pass them through a 60-mesh filter screen. The raw materials are weighed according to the feed formula, finely ground, and thoroughly mixed in a mixer. After adding oil (containing dissolved soybean isoflavones) and water (containing dissolved choline chloride and stachyose), the raw materials are fully mixed in a mixer with water for 30 minutes to form a dough. Then use an F-26II extrusion pellet machine to form particles with a diameter of 2 mm. Then the feed is naturally air-dried indoors (25°C) until the moisture content is reduced to about 10%, and finally stored in different sealed bags at -20°C until use.

[0034] Table 1 Experimental formula

[0035] Raw material (g / kg) Control group Experimental Group 1 Experimental Group 2 Experimental Group 3 Experimental Group 4 Casein 360 360 360 360 360 gelatin 90 90 90 90 90 Corn starch 250 250 250 250 250 Refined fish oil 30 60 60 60 60 Refined soybean oil 30 60 60 60 60 Vitamin premix 40 40 40 40 40 Mineral premix 20 20 20 20 20 Choline chloride 5 5 5 5 5 cholesterol 5 5 5 5 5 Lecithin 10 10 10 10 10 Betaine 30 30 30 30 30 Sodium Carboxymethyl Cellulose 20 20 20 20 20 BHT 1 1 1 1 1 Soy Isoflavones 0 0 0.04 0 0.04 Stachyose 0 0 0 12.42 12.42 Microcrystalline Cellulose 109.00 49.00 48.96 36.58 36.54 Nutritional content (%) Moisture 12.30 12.39 12.35 12.59 12.14 Crude Protein 43.51 43.59 43.57 43.60 43.64 Crude fat 7.01 13.01 13.21 13.37 12.72 Ash 2.97 2.89 3.10 2.93 2.83

[0036] Note: Soy isoflavones purity ≥99%, stachyose purity ≥80%.

[0037] Among them, the vitamin premix includes one or more mixtures of vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, vitamin D3, vitamin E, vitamin K3, niacin, D-calcium pantothenate, DL-calcium pantothenate, folic acid, D-biotin and choline chloride, aspartic acid, glutamic acid; the mineral premix includes one or more mixtures of compounds of sodium, potassium, calcium, magnesium, iron, copper, zinc, manganese, selenium, cobalt, molybdenum, chromium, phosphorus, chlorine and iodine.

[0038] Test example

[0039] The experiment was conducted at the experimental base of Shanghai Fisheries Research Institute, and Chinese mitten crab juveniles were purchased from a local farm. Juvenile crabs were temporarily raised in a concrete pool (9 meters long and 2 meters wide) for 7 days to adapt to the new environment, and were fed with basic feed during this period to adapt to the experimental feed. Before the formal experiment was carried out, 20 breeding barrels (300L) were randomly selected and numbered. After the temporary raising, 800 healthy juvenile crabs with intact appendages (0.61±0.01g) were randomly selected and divided into 5 groups: control group: normal feed; experimental group 1: high-fat feed; experimental group 2: high-fat feed + 40mg / kg soy isoflavones; experimental group 3: high-fat feed + 10g / kg stachyose; experimental group 4: high-fat feed + 40mg / kg soy isoflavones + 10g / kg stachyose. Juvenile crabs were randomly assigned to breeding barrels, 40 in each breeding barrel, and 4 replicates for each treatment. All juvenile crabs were weighed individually to ensure similar size, and the total weight difference of juvenile crabs in each breeding barrel was controlled within ±5%. Four arched tiles and four sets of corrugated plastic pipes were placed in each culture bucket as shelters to reduce aggressive behavior of juvenile crabs. During the 56-day culture period, the corresponding experimental feed was fed at 07:00, 14:30 and 21:00 every day at 4% of the juvenile crab body weight. The juvenile crabs in each culture bucket were weighed weekly to ensure that the juvenile crabs were fed at 4% of their body weight every day. Feed residues and feces were sucked out with a siphon after 2 hours of feeding, and one-third of the water in the culture bucket was replaced every morning. Dead crabs were taken out and molting was recorded every day. The experiment was carried out under a natural light cycle. The environmental conditions were water temperature 22-27℃, pH7.5-8.4, dissolved oxygen>7.0mg / L, and ammonia nitrogen<0.05mg / L.

[0040] After the breeding experiment, the juvenile crabs were fasted for 24 h to stabilize their physiological and metabolic states, and the juvenile crabs were counted and weighed to calculate the terminal body weight (FBW). After fasting, only juvenile crabs in the intermolting period were collected. Four crabs were randomly selected from each breeding bucket and stored at -20°C for whole body composition analysis. After ice anesthesia, 10 crabs were randomly selected from each breeding bucket, and leg joint hemolymph was extracted with a 1 mL syringe without anticoagulant. The supernatant was then collected and stored at -80°C after centrifugation at 3000 rpm at 4°C for 10 minutes for subsequent detection of other biochemical indicators. After collecting the hemolymph samples, the juvenile crabs were quickly dissected, and the hepatopancreatic tissues were collected, immediately frozen in liquid nitrogen, and then stored at -80°C for approximate composition, enzyme activity and gene expression analysis.

[0041] The growth-related parameters were calculated as follows:

[0042] Weight gain rate (WG, %) = 100% × (final body weight (g) - initial body weight (g)) / initial body weight (g);

[0043] Specific growth rate (SGR, % / d) = 100% × [ln final body weight (g) - ln initial body weight (g)] / 56 days;

[0044] Survival rate (SR, %) = 100% × (final number of crabs / initial number of crabs);

[0045] Liver to body ratio (HIS, %) = 100% × hepatopancreas weight / crab weight.

[0046] (1) Investigate the effects of feed additives on the growth performance and liver-to-body ratio of river crabs

[0047] Results Figure 1 ,Depend on Figure 1 It can be concluded that although adding soy isoflavones alone to high-fat feed can significantly improve growth performance, it does not reduce the liver-to-body ratio and does not alleviate lipid accumulation induced by high-fat feed; after combined supplementation with stachyose, it not only further promotes the growth performance of river crabs, but also significantly reduces the liver-to-body ratio.

[0048] (2) Investigate the effects of feed additives on the body composition of river crabs

[0049] Results Figure 2 ,from Figure 2It can be concluded that adding soy isoflavones alone or in combination with stachyose to high-fat feed can significantly increase the crude protein content of whole crabs; high-fat feed significantly increased the crude fat content in whole crabs, hepatopancreas and muscle, indicating that high-fat feed caused abnormal lipid accumulation in young crabs, while adding soy isoflavones or stachyose alone did not alleviate it, indicating that high-fat feed reduced the bioavailability of soy isoflavones, making it impossible to reverse the lipid deposition caused by high-fat feed; after combined supplementation with stachyose, the crude fat content in whole crabs and hepatopancreas was significantly reduced, indicating that stachyose can improve the bioavailability of soy isoflavones in lipid metabolism and can enhance the effect of isoflavones in promoting weight gain by inhibiting the accumulation of crab fat.

[0050] (3) Investigate the effects of feed additives on gene expression or enzyme activity related to soybean isoflavone metabolism in crabs

[0051] Results Figure 3 ,from Figure 3 It can be concluded that compared with the control group, the high-fat diet caused a significant upregulation of the expression of phase II metabolic enzymes (ugt and sult) and efflux transporter (abcb1 and mrp) genes in the intestine, which caused a significant increase in the efflux metabolism of soy isoflavones, reducing their content circulating in the body, thereby reducing the bioavailability of soy isoflavones, and there was no improvement after supplementing soy isoflavones; after adding stachyose alone or combining soy isoflavones and stachyose, the expression of intestinal phase II metabolic enzymes and efflux transporter genes was significantly reduced, and the expression of hepatopancreas in the liver and pancreas was significantly upregulated. The expression of intestinal phase II metabolic enzyme genes showed that stachyose could significantly reduce the excretion of soy isoflavones in the intestine and enhance their metabolic utilization in the hepatopancreas, thereby reducing their bioavailability. At the same time, high-fat diet caused a significant decrease in the activity of β-GC enzyme (which can cleave the β-glucosidic bond in soy isoflavones and convert glycosides into a more biologically active aglycone form) in the intestine of river crabs, verifying that high-fat diet would reduce the bioavailability of soy isoflavones. After adding stachyose or jointly supplementing soy isoflavones and stachyose, the activity of β-GC enzyme gradually recovered to the same level as the control group.

[0052] (4) Investigate the effects of feed additives on the physiological and biochemical parameters of the hepatopancreas of river crabs

[0053] Results Figure 4 ,from Figure 4 It can be concluded that high-fat diet caused a significant increase in the TG, T-CHO and NEFA contents in the hepatopancreas, and the addition of soy isoflavones alone did not significantly alleviate the problem. However, after supplementing with stachyose to improve the bioavailability of soy isoflavones, the TG, T-CHO and NEFA contents in the hepatopancreas were significantly reduced.

[0054] (5) Investigate the effects of feed additives on the physiological and biochemical parameters of crab hemolymph

[0055] Results Figure 5 ,from Figure 5 It can be concluded that high-fat diet causes a significant increase in the levels of TG, T-CHO and LDL-C in hemolymph, but whether adding soy isoflavones and stachyose alone or supplementing them together can significantly reduce the levels of TG and T-CHO. Only the combined supplementation of the two can significantly reduce the LDL-C content.

[0056] (6) Investigate the effect of feed additives on the antioxidant capacity of crabs

[0057] Results Figure 6 ,from Figure 6 It can be concluded that the addition of soy isoflavones alone can significantly reduce the MDA content in the hepatopancreas and significantly increase the activity of antioxidant enzymes, and the combined supplementation of soy isoflavones and stachyose can more effectively enhance the antioxidant capacity of river crabs and inhibit the oxidative stress induced by high-fat diet, indicating that the two have a synergistic effect in antioxidant effects.

[0058] (7) Investigate the effects of feed additives on lipid metabolism of crabs

[0059] Results Figure 7 ,from Figure 7 It can be concluded that soy isoflavones did not activate the mTOR pathway to increase protein synthesis. The reason for the increase in crude protein in whole crabs may be that soy isoflavones reduce protein metabolism or degradation; soy isoflavones may reduce the PI3K / AKT pathway and activate the AMPK pathway, thereby downregulating related fat synthesis genes (srebp1, elovl6, fas, dagt and △9fad) and fatty acid uptake genes (fabp3, fabp9 and fabp10), and upregulating fatty acid decomposition genes (cpt1a, cpt1b and cpt2) and fat transport gene mttp to optimize the abnormal lipid metabolism caused by high-fat diet and reduce lipid accumulation in the hepatopancreas.

[0060] In the description of this specification, the description with reference to the term "specific embodiment" or the like means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.

[0061] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. Application of stachyose in improving the bioavailability of soybean isoflavones.

2. A feed additive for improving lipid metabolism of Chinese mitten crab, characterized in that: The feed additive comprises soybean isoflavones and stachyose.

3. The feed additive according to claim 1, characterized in that Each kilogram of feed includes the following weights of feed additives: 30-50 mg of soy isoflavones and 10-15 g of stachyose.

4. Use of the feed additive according to any one of claims 2 to 3 in preparing a feed capable of improving lipid metabolism in Chinese mitten crab.

5. The use according to claim 4, characterized in that: The feed additive significantly reduces the crude fat content in the whole crab and hepatopancreas of Chinese mitten crab.

6. The use according to claim 4, characterized in that: The feed additive significantly reduces the expression of intestinal phase II metabolic enzymes and efflux transporter genes in Chinese mitten crabs, significantly upregulates the expression of intestinal phase II metabolic enzyme genes in the hepatopancreas, and improves the activity of β-GC enzyme.

7. The use according to claim 4, characterized in that: The feed additive significantly reduces the contents of TG, T-CHO and NEFA in the hepatopancreas of Chinese mitten crab.

8. The use according to claim 4, characterized in that: The feed additive significantly reduces the content of LDL-C in the hemolymph of Chinese mitten crab.

9. The use according to claim 4, characterized in that: The feed additive effectively enhances the antioxidant capacity of the hepatopancreas of Chinese mitten crab and inhibits the oxidative stress induced by a high-fat diet.

10. The use according to claim 4, characterized in that: The feed additive reduces the PI3K / AKT pathway and activates the AMPK pathway, thereby downregulating the fat synthesis genes srebp1, elovl6, fas, dagt, △9fad and the fatty acid uptake genes fabp3, fabp9, fabp10, and upregulating the fatty acid decomposition genes cpt1a, cpt1b, cpt2 and the fat transport gene mttp, so as to optimize the abnormal lipid metabolism caused by high-fat feed and reduce lipid accumulation in the hepatopancreas.